A sustained-release pranoprofen preparation is disclosed. The preparation comprises an effective amount of pranoprofen and one or more sustained-release components selected from the group consisting of oily components, water-soluble components, water-insoluble components, and intestinally soluble components. It controls release of pranoprofen and lowers the maximum pranoprofen concentration in blood, maintaining its concentration in blood at a certain level for a long period of time. It reduces risks of side effects and can effectively treat diseases with dosing once or twice a day.
本发明公开了一种
普拉洛芬缓释制剂。该制剂由有效量的
普拉洛芬和一种或多种缓释成分组成,这些缓释成分选自油性成分、
水溶性成分、
水不溶性成分和肠溶性成分组成的组。它能控制
普拉洛芬的释放,降低血液中
普拉洛芬的最高浓度,使血液中的浓度长期保持在一定
水平。它能降低副作用的风险,每天用药一到两次,就能有效治疗疾病。